Nikki Shandell Fox, DO Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 7235 Boat Club Rd, Ft Worth, TX 76179 Phone: 817-677-9535 Fax: 817-677-9536 |
Lacresha Quwanish Carson, FNP-BC Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6213 Ryan Creek Rd, Ft Worth, TX 76179 Phone: 903-701-8032 |
Ashley Whitener, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4830 South Fwy Ste B, Ft Worth, TX 76115 Phone: 817-926-0012 |
Mark H Bussell, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 6116 Oakbend Trail, 112, Ft Worth, TX 76132 Phone: 817-346-7800 Fax: 817-346-7408 |
News Archive
Devastating blood-borne fungal infections that can be lethal for HIV/AIDS, cancer, and organ transplant patients may be treated more successfully, thanks to a new drug delivery method developed by researchers at the University of British Columbia in Vancouver.
To increase access to advanced neurological care, Christiana Care Health System has opened the first Epilepsy Monitoring Unit in the First State.
Under a recently signed agreement, the U.S. Department of Energy's (DOE) Savannah River National Laboratory (SRNL) and the Ukraine's International Radioecology Laboratory (IRL) will collaborate on radiation ecology research, including projects in the region impacted by the catastrophic accident at the Chernobyl Nuclear Power Plant 24 years ago. Researchers at IRL use the area around Chernobyl as an extensive laboratory for studying the effects of radioactive contamination and methods of decontamination.
Given that cancer is a disease caused by gene mutations, cancer researchers have been striving to develop gene therapies aimed at correcting these mutations. However, these efforts have been hobbled by the difficulty in safely and efficiently delivering anticancer genes to tumors. Nanoparticles, however, may solve these delivery issues, and two recently published studies, using two different types of nanoparticles, lend credence to that hypothesis.
After five years of follow-up, a majority of asymptomatic, benign thyroid nodules exhibited no significant change in size, or actually decreased in size, and diagnoses of thyroid cancer were rare, according to a study in the March 3 issue of JAMA.
› Verified 5 days ago